sonnet biotherapeutics stock target price
While ratings are subjective and will change the latest Sonnet BioTherapeutics SONN rating was a maintained with a price target of 200 to 2200. This is based on 1 Wall Streets Analysts 12-month price targets issued in the past 3 months.
Sonn Stock Price And Chart Nasdaq Sonn Tradingview
No competitors data available.
. Market Data copyright 2022 QuoteMediaData delayed 15 minutes unless. In terms of how SONNET BIOTHERAPEUTICS HOLDINGS INC fares relative to all US stocks note that its average analyst price target is higher than 7883 of that group. Analyst ratings historical stock prices earnings estimates actuals.
3 Wall Street analysts that have issued a 1 year SONN price target the average SONN price target is 200. 4 Sonnet BioTherapeutics Insider Details. 2022 Sonnet BioTherapeutics Inc.
Sonnet BioTherapeutics Appoints Ms. Change in Directors or Principal Officers Regulati. Sonnet BioTherapeutics Price Targets.
Privacy Policy Disclaimer Sitemap. April 6 2020. 3 Insight into Sonnet BioTherapeutics.
View the latest SONN stock quote and chart on MSN Money. In terms of how. Analyze Sonnet BioTherapeutics target price and analyst consensus to evaluate buy or sell recommendation on Sonnet BioTherapeutics.
Find the latest Sonnet BioTherapeutics Holdings Inc H3D0BE stock quote history news and other vital information to help you with your stock trading and investing. Our clinical-stage pipeline comprises five. Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics has a Price Target of 33. According to 8 stock analysts the average 12. Sonnet BioTherapeutics presently has a consensus price target of 2800 indicating a potential upside of 180476.
Lori McNeill to the Board of Directors and. The highest analyst price. Sonnet BioTherapeutics Holdings Inc.
What analysts think SONN stock price will be. SONN IEX Real-Time Price USD. Based on short-term price targets offered by two analysts the average price target for Sonnet BioTherapeutics Holdings Inc.
HSA for transport to target tissues. Sonnet BioTherapeutics Holdings Inc NASDAQ. Sonnet Biotherapeutics Holdings Inc.
Find real-time SONN - Sonnet Biotherapeutics Holdings Inc stock quotes company profile. The average Sonnet Biotherapeutics Holdings stock price. The average price target for Sonnet BioTherapeutics Holdings is 2200.
SONN priced the underwritten public offering of 353. At Sonnet BioTherapeutics we are taking the fight directly to cancer. SONN updated stock price target summary.
Sonnet BioTherapeutics Stock Slumps After 30M Equity Raise.
Sonnet Biotherapeutics Holdings Inc Trade Ideas Nasdaq Sonn Tradingview
Sonnet Biotherapeutics Stock Nasdaq Sonn Quotes And News Summary Benzinga
Sonnet Biotherapeutics Holdings Inc Sonn Stock 10 Year History
Sonn Stock Review Sonnet Biotherapeutics Holdings Inc Youtube
Sonnet Biotherapeutics Holdings Sonn 6 Price Charts 2006 2022 History
Sonnet Biotherapeutics Holdings Sonn 6 Price Charts 2006 2022 History
Sonnet Biotherapeutics Holdings Inc Trade Ideas Nasdaq Sonn Tradingview
Sonn Btig Thinks Sonnet Biotherapeutics Holdings Stock Is Going To Recover
Sonnet Biotherapeutics Holdings Inc Sonn Stock Price Quote News Stock Analysis
Sonn Stock The Social Media Buzz Sending Sonnet Bio Rocketing Today Investorplace
Buy Sonnet Biotherapeutics Stock Sonn Stock Price Today News Public Com
Sonn Stock The Social Media Buzz Sending Sonnet Bio Rocketing Today Investorplace
Sonnet Biotherapeutics Stock Nasdaq Sonn Quotes And News Summary Benzinga
Sonnet Biotherapeutics Inc Sonn
Sonnet Biotherapeutics Holdings Sonn 6 Price Charts 2006 2022 History
Sonn Stock Forecast Price News Sonnet Biotherapeutics
Sonnet Biotherapeutics Holdings Inc Trade Ideas Nasdaq Sonn Tradingview
See Why Sonnet Biotherapeutics Stock Is Skyrocketing In Premarket Tuesday Sonnet Biotherapeutics Nasdaq Sonn Benzinga
Sonnet Biotherapeutics Updates 1 Key Risk Factor Nasdaq